US responds to drugmakers’ IRA counteroffers as Medicare price negotiations continue

CMS wants fur­ther dis­cus­sions with phar­ma com­pa­nies that are par­tic­i­pat­ing in IRA price ne­go­ti­a­tions, HHS an­nounced on Tues­day.

The agency said it has re­spond­ed to coun­terof­fers pro­posed by all of the par­tic­i­pat­ing man­u­fac­tur­ers, but de­clined to com­ment fur­ther. Ac­cord­ing to CMS’ guide­lines, the agency will now hold up to three ne­go­ti­a­tion meet­ings with the com­pa­nies be­fore ne­go­ti­a­tions end Aug. 1.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.